Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in
M A Akhavani1, H Larsen, E Paleolog
1Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College, London, UK
Insights
Cardiovascular disease, a leading cause of death, involves heart and blood vessel conditions. Reduced endothelial progenitor cells may drive disease progression and increase risks in rheumatoid arthritis patients.
Area of Science:
- Cardiovascular science and regenerative medicine.
Background:
- Cardiovascular disease (CVD) is a primary cause of death globally, particularly in Western countries.
- Atherosclerosis, a key feature of CVD, is linked to defective vascular repair and reduced circulating endothelial progenitor cells.
- Rheumatoid arthritis (RA) patients exhibit a higher incidence of CVD, including stroke and myocardial infarction.
Purpose of the Study:
- To review the evidence linking endothelial progenitor cells (EPCs) to cardiovascular disease development.
- To explore the potential reasons for increased CVD risk in rheumatoid arthritis patients concerning EPC function.
Main Methods:
- Literature review of current evidence on EPCs and cardiovascular disease.
- Analysis of studies investigating the role of EPCs in atherosclerosis and vascular repair.
- Examination of research on RA and its association with cardiovascular risk factors and EPCs.
Main Results:
- Defective vascular repair, potentially due to reduced EPCs, contributes to atherosclerosis.
- Lower levels of circulating EPCs are observed in individuals with cardiovascular disease.
- RA patients show a heightened risk of cardiovascular events, possibly related to altered EPC function.
Conclusions:
- Endothelial progenitor cells play a critical role in vascular health and cardiovascular disease pathogenesis.
- Dysfunction or reduction in EPCs is a significant factor in the development and progression of cardiovascular disease.
- Further research is warranted to understand the specific mechanisms linking rheumatoid arthritis, endothelial progenitor cells, and increased cardiovascular risk.
Abstract:
Cardiovascular disease refers to the class of diseases that involve the heart and/or blood vessels (arteries and veins). Most Western countries face high and ever-increasing rates of cardiovascular disease. Each year, more Americans are killed by heart disease than by cancer. Diseases of the heart alone cause 30% of all deaths, with other diseases of the cardiovascular system causing substantial further deaths and disability. Indeed, cardiovascular disease is the major cause of death and disability in the USA and most European countries. The development of the vascular systems requires an intricate interplay of molecules such as vascular endothelial growth factor and endothelial progenitor cells. A defective vascular repair/regeneration is thought to be responsible for propagation of atherosclerosis, a key feature of cardiovascular disease. This is partly attributed to a reduction in the circulating endothelial progenitor cells in peripheral blood. Patients with rheumatoid arthritis (RA) have a higher than average incidence of cardiovascular disease in comparison with the general population, with an increased risk of stroke and myocardial infarction, and an increased risk of fatality following myocardial infarction. This review focuses on the current evidence linking the role played by endothelial progenitor cells to the development of cardiovascular disease and why this might relate to the increased risk observed in RA patients.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Inflammatory Response I: Vascular and Cellular
Regulation of Angiogenesis and Blood Supply
Peripheral Artery Disease I: Introduction
